At Pharmerit, we conduct multidimensional research to support your product through its entire lifecyle. Our end-to-end, integrated support model will assist you in launching your product and ensure optimal pricing and reimbursement. Visit us at Booth #807 at the Annual AMCP Meeting in San Diego to discuss our services to demonstrate value for market access through strategic engagement with payers pre and post launch.
Our senior colleagues Dipen Patel, Jyoti Aggarwal, Yu-Chen Yeh, and Beth Lesher will be available to speak with you regarding how Pharmerit can support your HEOR, market access, value communications, and real-world evidence needs.
We are pleased to present examples of how we use evidence to bring healthcare innovations to patients.
C13: Characteristics and Treatment Patterns for Non-Metastatic Castration Resistant Prostate Cancer (nmCRPC) Patients in the United States (US)
Presented by: Ruchit Shah, BPharm, PhD
C18: Lifetime Costs of Urothelial Carcinoma by Stage at Diagnosis
Presented by: AstraZeneca
F5: Impact of RBP-6000 on Patient-reported Outcomes in Patients with Opioid Use Disorder: Results of a Randomized, Placebo-controlled, Phase 3 Study
Presented by client